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A B S T R A C T
Mitral annular calciﬁcation (MAC) is frequently observed, but it rarely causes left ventricular outﬂow
tract (LVOT) obstruction (LVOTO). An 83-year-old woman with hypertension, diabetes, and dyslipidemia
was admitted to our hospital because of exertional dyspnea. She was diagnosed with hypertensive heart
disease. Her symptoms were exacerbated by exertion, and she had no symptoms at rest. Transthoracic
echocardiography showed massive posterior MAC, a sigmoid septum, and LVOTO, with a peak gradient of
15.4 mmHg at rest. Systolic anterior motion of the anterior mitral leaﬂet was not found. Moreover, the
LVOT gradient in the stress condition was evaluated, and an increased LVOT gradient (47.3 mmHg) and
chest discomfort was noted after 20 mg/kg/min of dobutamine was administered and the Valsalva
maneuver was used. Hence, the patient was diagnosed with latent LVOTO. Interestingly, the distance
between the septal wall, which was protruding into the left ventricular cavity, and the mitral valve
coaptation, which was pushed up by the posterior MAC, had become closer, causing dynamic LVOTO.
Since it is difﬁcult to treat LVOTO with medication, ultimately, septal myectomy and mitral valve
replacement were performed, which improved her symptoms. Evaluating the LVOT pressure gradient in
stress condition is important in patients with MAC.
<Learning objective: Mitral annular calciﬁcation (MAC) is commonly found in older people. However, it is
not well known that MAC can cause left ventricular outﬂow tract obstruction (LVOTO). In the present case,
massive posterior MAC was one of the factors that caused LVOTO. Left ventricular hypercontractility and a
sigmoid septum were found to contribute to LVOTO, and stress echocardiography was useful for detecting
the latent LVOTO. It is interesting that MAC can contribute to LVOTO in a stress condition.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Left ventricular outﬂow tract (LVOT) obstruction (LVOTO) is
dynamic and is typically observed in those with hypertrophic
cardiomyopathy. Hypertensive heart disease (HHD) leading to LV
hypertrophy, LV hypercontractility, and a sigmoid septum are the
important factors that cause LVOTO [1]. Symptoms such as dyspnea,
syncope, chest pain, and fatigue are induced by LVOTO, and they are
often exacerbated by exertion; thus, stress echocardiography is
useful for detecting latent LVOTO in patients without symptoms* Corresponding author at: Department of Cardiology, Ako City Hospital, 1090,
Nakahiro, Ako-shi, Hyogo 6780232, Japan. Tel.: +81 791 43 3222;
fax: +81 791 43 0351.
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1878-5409/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsat rest [2]. Although previous studies have reported that mitral
annular calciﬁcation (MAC) can also cause LVOTO [3,4], this is not
well known.
Herein, we report a case in which latent LVOTO was caused by
MAC. In particular, the massive posterior MAC pushed up the
mitral valve coaptation. A sigmoid septum and an anteriorly
displaced mitral valve coaptation then caused LVOTO, especially in
the stress condition.
Case report
An 83-year-old woman was admitted to our hospital because
of exertional dyspnea. She had a history of hypertension
(and underwent treatment with antihypertensive medications for
30 years), diabetes, and dyslipidemia. The presence of high blood reserved.
Fig. 1.
Transthoracic echocardiography at rest (A,B) and after administering 20 mg/kg/min of dobutamine and using the Valsalva maneuver (C,D). (A) Apical long-axis
view of the end-systolic period showing massive posterior mitral annular calciﬁcation and a sigmoid septum. (B) Continuous wave Doppler across the left
ventricular outﬂow tract (LVOT) demonstrates a peak velocity of 1.96 m/s (equivalent to a peak gradient of 15.4 mmHg). (C) During the systolic period, the
distance between the septal wall and mitral annular calciﬁcation becomes closer. (D) Continuous wave Doppler across the LVOT demonstrates a peak velocity of
3.44 m/s (equivalent to a peak gradient of 47.3 mmHg).
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HHD, and she was taking carvedilol 20 mg daily, olmesartan 20 mg
daily, and azosemide 30 mg daily. She had no family history of heart
disease. On admission, her vital signs showed a blood pressure of
127/68 mmHg and heart rate of 66 beats/min. Although there were
no rales or rhonchi, a systolic murmur (Levine 3/6) was noted at the
fourth left sternal border; however, squatting decreased the systolic
murmur. Laboratory evaluation revealed a B-type natriuretic
peptide level of 54 pg/mL. The transthoracic echocardiography
showed a LV end-diastolic diameter of 36.6 mm, a LV end-systolicFig. 2.
Transesophageal echocardiography. (A) A mid esophageal long-axis view. The
16 mm, respectively. (B) The surgeon’s view of the three-dimensional transe
annulus (white arrow) and the anterolateral mitral annulus (black arrow). Adiameter of 23.3 mm, a LV end-diastolic volume of 63.5 ml, a LV end-
systolic volume of 15.2 ml (a LV ejection fraction of 76.1% with
biplane Simpson’s method), an interventricular septal thickness of
15.8 mm, a LV posterior wall thickness of 14.6 mm, and a sigmoid
septum. Massive posterior MAC was also found (Fig. 1A). In addition,
the LVOT pressure gradient was 15.4 mmHg at rest (Fig. 1B). Systolic
anterior motion (SAM) of the mitral leaﬂet was not found, and mitral
regurgitation was mild. Transesophageal echocardiography showed
calciﬁcation of the entire posterior and anterolateral mitral annulus
(Fig. 2A,B). Cardiac catheterization revealed a normal coronary lengths of the anterior mitral leaﬂet and posterior mitral leaﬂet were 26 mm and
sophageal echocardiography showing calciﬁcation of the entire posterior mitral
V, aortic valve.
Fig. 3.
Histopathology of the myocardium. (A) Hematoxylin eosin stain showing moderate hypertrophy. (B) Masson trichrome stain showing ﬁbrosis around the blood
vessels (arrow).
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which was not signiﬁcant. Her symptoms were exacerbated by
exertion, and they were not apparent at rest. Exertional dyspnea
developed immediately when she walked. Therefore, the LVOT
pressure gradient in the stress condition was evaluated. Her vital
signs showed a blood pressure of 95/51 mmHg and heart rate of
51 beats/min at rest, and a blood pressure of 143/69 mmHg, and
heart rate of 69 beats/min after 20 mg/kg/min of dobutamine was
administered. We noted that the distance between the sigmoid
septum, which was protruding into the LV cavity, and the mitral
valve coaptation, which was pushed up by the posterior MAC, had
become closer, causing an increased LVOT pressure gradient
(47.3 mmHg) and chest discomfort after 20 mg/kg/min of dobuta-
mine was administered and the Valsalva maneuver was used
(Fig. 1C,D). Thus, we diagnosed the patient with latent LVOTO. The
grade of mitral regurgitation changed from trace to mild during
stress echocardiography.
We discontinued olmesartan and azosemide, and changed beta-
blocker from carvedilol 20 mg daily to bisoprolol 5 mg daily not to
reduce preload and afterload. Additionally, cibenzoline 300 mg
daily was initiated, however, it was difﬁcult to reduce her
symptoms; thus, septal myectomy and mitral valve replacement
were performed. Histopathological examination of the myocardi-
um revealed moderate hypertrophy and ﬁbrosis around the blood
vessels, although no disarray was noted (Fig. 3).
The postoperative transthoracic echocardiography showed a LV
end-diastolic diameter of 35.1 mm, a LV end-systolic diameter
21.0 mm, a LV end-diastolic volume of 44.3 ml, a LV end-systolic
volume of 13.9 ml (a LV ejection fraction of 68.6%), and an
interventricular septal thickness of 12.7 mm. One month after
operation, dobutamine stress echocardiography with the Valsalva
maneuver was performed, and there was no LVOTO.
Discussion
Although LVOTO is typically observed in cases with hypertro-
phic cardiomyopathy, it can be observed in other conditions,
including acute myocardial infarction, takotsubo cardiomyopathy,
a sigmoid septum, SAM of the mitral leaﬂets, LV hypercontractility,
exercise, dehydration, and anemia [5]. Previous studies have
reported that MAC can also cause LVOTO due to SAM of the mitral
leaﬂet [3,4]. In the present case, we report on a novel mechanism of
LVOTO that involves MAC. LVOTO was caused by a combination of
a sigmoid septum, LV hypercontractility, small LV, and MAC. In
particular, massive posterior MAC caused anterior displacement of
the mitral valve coaptation during the systolic period. However,SAM of the anterior mitral leaﬂet was not found. MAC moved in a
longitudinal direction while the sigmoid septum moved into the LV
cavity, which coupled with LV hypercontractility and a small heart.
Therefore, the distance between the mitral valve coaptation and
sigmoid septum became closer, leading to LVOTO. Previous reports
have showed that mitral leaﬂet lengths and mobility were the
important factors causing SAM of the mitral leaﬂet [6]. As shown in
Fig. 2A, the respective length of the anterior leaﬂet (AL) was 26 mm
and of the posterior leaﬂet (PL) was 16 mm (AL/PL ratio 1.6); in
addition the PL was degenerative and had low mobility. Further-
more, mitral regurgitant jets went straight into the left atrium.
Hence, we considered that SAM was not induced in this patient.
Since the LVOT pressure gradient increases in stress conditions, it
is important to evaluate the LVOT pressure gradient in stress
conditions to detect latent LVOTO. Stress tests can be classiﬁed into
two groups: an exercise and pharmacologic stress test. In the present
case, it was difﬁcult to measure the correct LVOT pressure gradient
during exercise stress echocardiography because of the patient’s low
exercise tolerance. Dobutamine stress echocardiography was used
as a substitute for exercise [7]. Furthermore, the LVOT pressure
gradient also changed according to the patient’s position [8]. An
orthostatic position increased the LVOT pressure gradient, because it
reduced the preload. Since her symptoms were apparent in the
orthostatic position, the Valsalva maneuver was useful to decrease
preload. As she was taking carvedilol 20 mg/day, changes in heart
rate during dobutamine stress echocardiography were modest.
Therefore, only dobutamine stress was insufﬁcient to evaluate the
dynamic obstruction of LVOT. In order to increase contractility and
to decrease preload, dobutamine stress and the Valsalva maneuver
were performed simultaneously. Previous reports have shown that
the simple and safe Valsalva maneuver plays an effective role during
dobutamine stress echocardiography [9]. It is a possibility that we
underestimated the peak pressure gradient because stress echocar-
diography was performed in recumbent position and normal saline
was administered during stress echocardiography.
A decrease in the intravascular blood volume may narrow the
LVOT and result in dynamic obstructions; therefore, we discon-
tinued the angiotensin II receptor blocker and diuretic. Neverthe-
less, her symptoms did not improve. Furthermore, we attempted to
use temporary external dual-chamber (DDD) pacing to evaluate
the LVOT pressure gradient. Although the LVOT pressure gradient
decreased during temporary external DDD pacing, a 6-min walk
test did not show any improvement. Therefore, a permanent
pacemaker was not implanted in the present case. Moreover,
percutaneous transluminal septal myocardial ablation (PTSMA) may
be a treatment choice for LVOTO [10]. However, in the present case,
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LVOTO, because MAC was one of the main factors leading to LVOTO.
Only septal myectomy or mitral valve replacement was also
insufﬁcient to decrease LVOTO and improve her symptoms. We
considered that only septal myectomy or mitral valve replacement
would be insufﬁcient to decrease LVOTO and improve her symptoms
because LVOTO was caused by both sigmoid septum and MAC, and
that both septal myectomy and mitral valve replacement appear to
be the only methods for improving LVOTO.
Based on the ﬁndings of the present case, it appears that MAC
can cause LVOTO. Moreover, evaluating the LVOT pressure
gradient in the stress condition is important in patients whose
symptoms are exacerbated by exertion.
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